Deep Track Capital

Venture capital firm
Greenwich, Connecticut, USA$8.4B AUMwww.deeptrackcapital.com

Venture capital firm specializing in biotechnology investments based in Greenwich, Connecticut.

Strategy

Stages
Pre-IPOPublic
Sectors
Biotechnology
Geographies
Greenwich, Connecticut, USA

Recent changes

  1. Sep 6, 2026Stages updated: Pre-IPO, Public deeptrackcapital.com
  2. Sep 5, 2026Sectors updated: Biotechnology deeptrackcapital.com

Portfolio

2 total
Attovia TherapeuticsTriveni Bio

Co-Investors

12
EcoR1 Capital · 1 sharedFrazier Life Sciences · 1 sharedGoldman Sachs Alternatives · 1 sharedIllumina Ventures · 1 sharedNextech Invest · 1 sharedSanofi Ventures · 1 sharedvenBio Partners · 1 sharedAscenta Capital · 1 sharedAtlas Venture · 1 sharedCormorant Asset Management · 1 sharedFidelity Investments · 1 sharedJanus Henderson Investors · 1 shared

Latest Pulse

Pulse coverage →
  1. Goldman-Backed Attovia Seeks $212.5M in Biotech IPOAttovia Therapeutics is seeking up to $212.5 million in a US IPO, offering 12.5 million shares at $15-$17 each, backed by Goldman Sachs Alternatives, Deep Track Capital, Frazier Life Sciences, and venBio.→

Suggest a correction